David Barrett

Chief Executive Officer • American Society for Gene and Cell Therapy (ASGCT)

David serves as the chief executive officer of the American Society of Gene and Cell Therapy, the primary membership organization for scientists, physicians, professionals, and patient advocates involved in gene and cell therapy. ASGCT’s mission is to advance knowledge, awareness, and education leading to discovery and clinical application of gene and cell therapies to alleviate disease.

David is an experienced executive and attorney with a proven track record of leading and growing non-profit organizations, specifically medical and scientific membership associations. Extensive experience navigating and providing counsel related to complex regulatory environments including drug, biologic, and device approvals; Medicare reimbursement for physician services; physician and ancillary health care licensure; as well as graduate medical and higher education compliance. Deep understanding of standard-setting, accreditation, and certification within several fields including healthcare, medical specialty, and higher education.

Also Speaking

Amritha Jaishankar

Executive Director, Cell and Gene Therapy Center • IQVIA

Ramona Repaczki-Jones

Executive Director, Commercial Treatment Center Operations, Cell Therapy • Iovance Biotherapeutics Inc

Matt Olsen

Fluid Management Technologies Manager • Sartorius Stedim Biotech

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.